Simcere Pharmaceutical Group Limited (FRA:S2P)

FRA:S2P Revenue

Simcere Pharmaceutical Group had revenue of 3.58B CNY in the half year ending June 30, 2025, with 6.01% growth. This brings the company's revenue in the last twelve months to 7.11B, up 12.10% year-over-year. In the year 2024, Simcere Pharmaceutical Group had annual revenue of 6.64B with 0.41% growth.

• Revenue (ttm): 7.11B CNY
• Revenue Growth: +12.10%
• P/S Ratio: 4.45
• Revenue / Employee: 1.08M CNY
• Employees: 6,584
• Market Cap: 3.76B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.64B	27.41M	0.41%
Dec 31, 2023	6.61B	283.72M	4.49%
Dec 31, 2022	6.32B	1.32B	26.49%
Dec 31, 2021	5.00B	491.00M	10.89%
Dec 31, 2020	4.51B	-527.94M	-10.48%